{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T02:50:39Z","timestamp":1761706239085,"version":"3.44.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.amjmed.2008.02.013","type":"journal-article","created":{"date-parts":[[2008,6,26]],"date-time":"2008-06-26T04:25:11Z","timestamp":1214454311000},"page":"562-564","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Perspectives on \u201cChronic Lyme Disease\u201d"],"prefix":"10.1016","volume":"121","author":[{"given":"Phillip J.","family":"Baker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2008.02.013_bib1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1056\/NEJM200107123450202","article-title":"Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease","volume":"345","author":"Klempner","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2008.02.013_bib2","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1212\/01.WNL.0000071227.23769.9E","article-title":"Study and treatment of post Lyme disease (stop-LD): a randomized double-masked clinical trial","volume":"60","author":"Krupp","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.amjmed.2008.02.013_bib3","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1086\/318138","article-title":"Death from inappropriate therapy for Lyme disease","volume":"31","author":"Patel","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjmed.2008.02.013_bib4","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s11894-001-0015-6","article-title":"Gall bladder sludge: what is its clinical significance?","volume":"3","author":"Shaffer","year":"2001","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.amjmed.2008.02.013_bib5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1592\/phco.26.3.299","article-title":"Clostridium difficile-associated disease: an emerging threat to patient safety: insights from the Society of Infectious Diseases Pharmacists","volume":"26","author":"Owens","year":"2006","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.amjmed.2008.02.013_bib6","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.amjmed.2007.04.001","article-title":"Antimicrobial resistance prevention initiative\u2014an update: proceedings of an expert panel","volume":"120","author":"Moellering","year":"2007","journal-title":"Am J Med"},{"key":"10.1016\/j.amjmed.2008.02.013_bib7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.7326\/0003-4819-136-5-200203050-00024","article-title":"Misconceptions about Lyme disease: confusions hiding behind ill-chosen terminology","volume":"136","author":"Sigal","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjmed.2008.02.013_bib8","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.tips.2004.10.001","article-title":"Neuroprotection by tetracyclines","volume":"25","author":"Domercq","year":"2004","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.amjmed.2008.02.013_bib9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nature03180","article-title":"\u03b2-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression","volume":"433","author":"Rothstein","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.amjmed.2008.02.013_bib10","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.nbd.2006.10.022","article-title":"Multiple neuroprotective mechanisms of minocycline in autoimmune CNS inflammation","volume":"25","author":"Maier","year":"2007","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.amjmed.2008.02.013_bib11","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000086441","article-title":"Gabapentin for the symptomatic treatment of chronic neuropathic pain in patients with late-stage Lyme borreliosis: a pilot study","volume":"211","author":"Weissenbacher","year":"2005","journal-title":"Dermatology"},{"key":"10.1016\/j.amjmed.2008.02.013_bib12","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America","volume":"43","author":"Wormser","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjmed.2008.02.013_bib13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1212\/01.wnl.0000265517.66976.28","article-title":"Practice parameter: treatment of nervous system Lyme disease (an evidence-based review)","volume":"69","author":"Halperin","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.amjmed.2008.02.013_bib14","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1056\/NEJMra072023","article-title":"A critical appraisal of \u201cchronic Lyme disease.\u201d","volume":"357","author":"Feder","year":"2007","journal-title":"N Engl J Med"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934308001812?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934308001812?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T08:47:42Z","timestamp":1757580462000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934308001812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":14,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S0002934308001812"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2008.02.013","relation":{},"ISSN":["0002-9343"],"issn-type":[{"type":"print","value":"0002-9343"}],"subject":[],"published":{"date-parts":[[2008,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perspectives on \u201cChronic Lyme Disease\u201d","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2008.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}